Activating HER3 mutations in breast cancer

Recent studies have highlighted a role of HER3 in ER and HER2-driven breast cancers. We sought to investigate the role of patient-derived HER3 mutations in ER+ and HER2+ breast cancer cells using ectopic expression of HER3 mutants. We found that HER3(T355I) mutant is activating with increased cell p...

Descripción completa

Detalles Bibliográficos
Autores principales: Mishra, Rosalin, Alanazi, Samar, Yuan, Long, Solomon, Thomas, Thaker, Tarjani M., Jura, Natalia, Garrett, Joan T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6021238/
https://www.ncbi.nlm.nih.gov/pubmed/29963236
http://dx.doi.org/10.18632/oncotarget.25576

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6021238/
https://www.ncbi.nlm.nih.gov/pubmed/29963236
http://dx.doi.org/10.18632/oncotarget.25576

Ejemplares similares